Sana Dastgheyb

Sana Dastgheyb

Auto-generated profile, based on publicly available information

Sana Dastgheyb

Department of Orthopaedic Surgery, University of Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Vaccine
Verified
Journal Article
Open access
BGBirgitte K Giersing
Birgitte K Giersing
SDSana S. Dastgheyb
Sana S. Dastgheyb
KMKayvon Modjarrad
Kayvon Modjarrad
VMVasee Moorthy
Vasee Moorthy
Staphylococcus aureus is a highly versatile gram positive bacterium that is resident as an asymptomatic colonizer on the skin and in the nasopharynx of approximately 30% of individuals. Nasopharyngeal colonization is a risk for acquiring S. aureus infections, which can cause a range of clinical symptoms that are commonly associated with skin and soft-tissue infections. The emergence of S. aureus strains that are highly resistant to antimicrobials has recently become a major public health concern. In low-income countries the incidence of S. aureus disease is highest in neonates and children up to one year of age and mortality rates are estimated to be up to 50%. In the United States, S. aureus infection accounts for approximately 300,000 hospitalizations per year. A vaccine against multi-drug resistant S. aureus, therefore, is urgently needed. Two vaccine candidates have previously been evaluated in late-stage clinical trials but have not demonstrated efficacy. At present, one vaccine candidate and two monoclonal antibody are undergoing clinical evaluation in target groups at high risk for S. aureus infection. This review provides an overview of current vaccine development efforts and presents the major technical and regulatory challenges to developing a licensed S. aureus vaccine.

26 November 2014 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
KLKatherine Y. Le
Katherine Y. Le
SDSana Dastgheyb
Sana Dastgheyb
THTrung V. Ho
Trung V. Ho
MOMichael Otto
Michael Otto
Staphylococci are frequently implicated in human infections, and continue to pose a therapeutic dilemma due to their ability to form deeply seated microbial communities, known as biofilms, on the surfaces of implanted medical devices and host tissues. Biofilm development has been proposed to occur in three stages: 1) attachment, 2) proliferation/structuring, and 3) detachment/dispersal. Although research within the last several decades has implicated multiple molecules in the roles as effectors of staphylococcal biofilm proliferation/structuring and detachment/dispersal, to date, only phenol soluble modulins (PSMs) have been consistently demonstrated to serve in this role under both in-vitro and in-vivo settings. PSMs are regulated directly through a density-dependent manner by the accessory gene regulator (Agr) system. They disrupt the non-covalent forces holding the biofilm extracellular matrix together, which is necessary for the formation of channels, a process essential for the delivery of nutrients to deeper biofilm layers, and for dispersal/dissemination of clusters of biofilm to distal organs in acute infection. Given their relevance in both acute and chronic biofilm-associated infections, the Agr system and the psm genes hold promise as potential therapeutic targets.

1 July 2015 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
SDSana S. Dastgheyb
Sana S. Dastgheyb
AVAmer E. Villaruz
Amer E. Villaruz
KLKatherine Y. Le
Katherine Y. Le
VTVee Y. Tan
Vee Y. Tan
ADAnthony C. Duong
Anthony C. Duong
MOMichael Otto
Michael Otto
Staphylococcus aureus is a leading cause of prosthetic joint infections, which we recently showed proceed with the involvement of biofilm-like clusters that cause recalcitrance to antibiotic treatment. Here we analyzed why these clusters grow extraordinarily large, reaching macroscopically visible extensions (> 1 mm). We found while specific S. aureus surface proteins are a prerequisite for agglomeration in synovial fluid, that low activity of the Agr regulatory system and subsequent low production of the phenol-soluble modulin (PSM) surfactant peptides cause agglomerates to grow to exceptional dimensions. Our results indicate that PSMs function by disrupting interactions of biofilm matrix molecules, such as the polysaccharide intercellular adhesin (PIA), with the bacterial cell surface. Together, our findings support a two-step model of staphylococcal prosthetic joint infection: As we previously reported, interaction of S. aureus surface proteins with host matrix proteins such as fibrin initiates agglomeration; our present results show that, thereafter, the bacterial agglomerates grow to extremely large sizes owing to the lack of PSM expression under the specific conditions present in joints. Our findings provide a mechanistic explanation for the reported extreme resistance of joint infection to antibiotic treatment, lend support to the notions that Agr functionality and PSM production play a major role in defining different forms of S. aureus infection, and have important implications for anti-staphylococcal therapeutic strategies.

1 April 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
SDSana S. Dastgheyb
Sana S. Dastgheyb
SHSommer Hammoud
Sommer Hammoud
CKConstantinos Ketonis
Constantinos Ketonis
ALAndrew Yongkun Liu
Andrew Yongkun Liu
KFKeith Fitzgerald
Keith Fitzgerald
NHNoreen J. Hickok
Noreen J. Hickok
Antibiotic prophylaxis is standard for patients undergoing surgical procedures, yet despite the wide use of antibiotics, breakthrough infections still occur. In the setting of total joint arthroplasty, such infections can be devastating. Recent findings have shown that synovial fluid causes marked staphylococcal aggregation, which can confer antibiotic insensitivity. We therefore asked in this study whether clinical samples of synovial fluid that contain preoperative prophylactic antibiotics can successfully eradicate a bacterial challenge by pertinent bacterial species. This study demonstrates that preoperative prophylaxis with cefazolin results in high antibiotic levels. Furthermore, we show that even with antibiotic concentrations that far exceed the expected bactericidal levels, Staphylococcus aureus bacteria added to the synovial fluid samples are not eradicated and are able to colonize model implant surfaces, i.e., titanium pins. Based on these studies, we suggest that current prophylactic antibiotic choices, despite high penetration into the synovial fluid, may need to be reexamined.

19 November 2015 in Future Microbiology
Verified
Journal Article
Closed access
SDSana S Dastgheyb
Sana S Dastgheyb
MOMichael Otto
Michael Otto
Host niches can differ strongly regarding, for example, oxygen tension, pH or nutrient availability. Staphylococcus aureus and other staphylococci are common colonizers of human epithelia as well as important human pathogens. The phenotypes that they show in different host environments, and the corresponding bacterial transcriptomes and proteomes, are currently under intense investigation. In this review, we examine the available literature describing staphylococcal phenotypes, such as expression of virulence factors, gross morphologic characteristics and growth patterns, in various physiological environments. Going forward, these studies will help researchers and clinicians to form an enhanced and more detailed picture of the interactions existing between the host and staphylococci as some of its most frequent colonizers and invaders.

1 May 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
MFM. Carme Coll Ferrer
M. Carme Coll Ferrer
SDSana Dastgheyb
Sana Dastgheyb
NHNoreen J. Hickok
Noreen J. Hickok
DEDavid M. Eckmann
David M. Eckmann
RCRussell J. Composto
Russell J. Composto